Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Granger

Showing results (61-70 of 133) with videos related to

Pageof 14
Sort By:
Circulation|April 1, 1995
Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromesC B Granger, J M Miller, E G Bovill, et al.
The American Journal of Cardiology|March 12, 1999
Correlation of angiographic findings and right (V1 to V3) versus left (V4 to V6) precordial ST-segment depression in inferior wall acute myocardial infarctionY Birnbaum, G S Wagner, G I Barbash, et al.
Journal of the American College of Cardiology|March 21, 1998
Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesC B Granger, R Becker, R P Tracy, et al.
Journal of the American College of Cardiology|December 19, 1998
Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes trialK P Alexander, E D Peterson, C B Granger, et al.
Journal of the American College of Cardiology|January 12, 2001
Shifting the open-artery hypothesis downstream: the quest for optimal reperfusionM T Roe, E M Ohman, A C Maas, et al.
Journal of the American College of Cardiology|June 17, 1998
Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) InvestigatorsB K Metz, H D White, C B Granger, et al.
American Heart Journal|January 8, 1999
Death and nonfatal reinfarction within the first 24 hours after presentation with an acute coronary syndrome: experience from GUSTO-IIb. Global Utilization of Strategies for Total OcclusionN S Kleiman, C B Granger, H D White, et al.
European Heart Journal|October 29, 2000
Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb InvestigatorsD K McGuire, H Emanuelsson, C B Granger, et al.
The American Journal of Cardiology|November 15, 1995
Frequency, significance, and cost of recurrent ischemia after thrombolytic therapy for acute myocardial infarction. TAMI Study GroupA Barbagelata, C B Granger, E J Topol, et al.
The American Journal of Cardiology|October 12, 2000
Clinical and electrocardiographic variables associated with increased risk of ventricular septal defect in acute anterior myocardial infarctionY Birnbaum, G S Wagner, K B Gates, et al.
Pageof 14

Showing results (61-70 of 133) with videos related to

Sort By:
Pageof 14
Circulation|April 1, 1995
Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromesC B Granger, J M Miller, E G Bovill, et al.
The American Journal of Cardiology|March 12, 1999
Correlation of angiographic findings and right (V1 to V3) versus left (V4 to V6) precordial ST-segment depression in inferior wall acute myocardial infarctionY Birnbaum, G S Wagner, G I Barbash, et al.
Journal of the American College of Cardiology|March 21, 1998
Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesC B Granger, R Becker, R P Tracy, et al.
Journal of the American College of Cardiology|December 19, 1998
Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes trialK P Alexander, E D Peterson, C B Granger, et al.
Journal of the American College of Cardiology|January 12, 2001
Shifting the open-artery hypothesis downstream: the quest for optimal reperfusionM T Roe, E M Ohman, A C Maas, et al.
Journal of the American College of Cardiology|June 17, 1998
Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) InvestigatorsB K Metz, H D White, C B Granger, et al.
American Heart Journal|January 8, 1999
Death and nonfatal reinfarction within the first 24 hours after presentation with an acute coronary syndrome: experience from GUSTO-IIb. Global Utilization of Strategies for Total OcclusionN S Kleiman, C B Granger, H D White, et al.
European Heart Journal|October 29, 2000
Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb InvestigatorsD K McGuire, H Emanuelsson, C B Granger, et al.
The American Journal of Cardiology|November 15, 1995
Frequency, significance, and cost of recurrent ischemia after thrombolytic therapy for acute myocardial infarction. TAMI Study GroupA Barbagelata, C B Granger, E J Topol, et al.
The American Journal of Cardiology|October 12, 2000
Clinical and electrocardiographic variables associated with increased risk of ventricular septal defect in acute anterior myocardial infarctionY Birnbaum, G S Wagner, K B Gates, et al.
Pageof 14